Loading analysis...
Loading Truth Social...
Loading live updates...
—
S&P 500— —
Nasdaq— —
Dow Jones— —
载入时间机器…
MRK 最新新闻
MRK 的最新新闻报道,汇总自华尔街日报、彭博、纽约时报、金融时报与 Google 新闻,实时更新,免费无广告。标题保留原文。
- Is Halozyme’s EU Injunction on Subcutaneous Keytruda Reshaping the Investment Case For Merck (MRK)?
- Dutch court orders Merck to halt Keytruda sales in Europe
- Halozyme wins court order to block Merck's injected Keytruda in select European markets
- Tempus AI Doubles Down On Moderna and Merck Cancer Vaccine Infrastructure
- Halozyme Therapeutics Stock: Setback for Merck Is Good News for This Biotech
- Halozyme stock rises after winning injunction against Merck
- Halozyme prevails in patent fight with Merck; Enliven readies anticipated leukemia trial
- Halozyme stock rises after winning injunction against Merck
- Dutch court halts Merck’s Keytruda SC in multiple EU markets
- Merck’s New Keytruda Shot Blocked in Europe After Court Loss
- Halozyme wins court order to block Merck's injected Keytruda in select European markets
- Tempus AI expands cancer therapy deal with Moderna, Merck
- Merck’s injectable Keytruda barred in Europe (MRK:NYSE)
- Tempus Announces Multi-Year Collaboration with Moderna and Merck
- Halozyme Wins Injunction Stopping Manufacture and Sale of Merck's Keytruda SC in Multiple European Markets
Settings
Appearance
Card Style
Language
Notifications
Live View Style
Trump Truth Social
About
Version
2.6.1
Data Source
r/wallstreetbets
AI Engine
ChatGPT/Gemini/Claude
MCP Server
https://mcp.sellthenews.org/mcp
Contact Us
[email protected]